Drug
Intraparenchymal Raav1 Rna Htt
Intraparenchymal Raav1 Rna Htt: highest development phase Phase 1, developed by Voyager Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Voyager Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| Intraparenchymal rAAV1 - (mi)RNA HTT NCT04885114 | Phase 1 | Huntington Disease |
Latest
No recent events.
Follow Intraparenchymal Raav1 Rna Htt on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.